Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 586

Related Citations for PubMed (Select 21711774)

1.

Novel docetaxel-loaded nanoparticles based on poly(lactide-co-caprolactone) and poly(lactide-co-glycolide-co-caprolactone) for prostate cancer treatment: formulation, characterization, and cytotoxicity studies.

Sanna V, Roggio AM, Posadino AM, Cossu A, Marceddu S, Mariani A, Alzari V, Uzzau S, Pintus G, Sechi M.

Nanoscale Res Lett. 2011 Mar 28;6(1):260. doi: 10.1186/1556-276X-6-260.

2.

Co-delivery of chemotherapeutic drugs with vitamin E TPGS by porous PLGA nanoparticles for enhanced chemotherapy against multi-drug resistance.

Zhu H, Chen H, Zeng X, Wang Z, Zhang X, Wu Y, Gao Y, Zhang J, Liu K, Liu R, Cai L, Mei L, Feng SS.

Biomaterials. 2014 Feb;35(7):2391-400. doi: 10.1016/j.biomaterials.2013.11.086. Epub 2013 Dec 19.

PMID:
24360574
3.

Cellular cytotoxicity and in-vivo biodistribution of docetaxel poly(lactide-co-glycolide) nanoparticles.

Esmaeili F, Dinarvand R, Ghahremani MH, Ostad SN, Esmaily H, Atyabi F.

Anticancer Drugs. 2010 Jan;21(1):43-52. doi: 10.1097/CAD.0b013e328331f934.

PMID:
19809300
4.

Cytotoxicity of Paclitaxel in biodegradable self-assembled core-shell poly(lactide-co-glycolide ethylene oxide fumarate) nanoparticles.

He X, Ma J, Mercado AE, Xu W, Jabbari E.

Pharm Res. 2008 Jul;25(7):1552-62. doi: 10.1007/s11095-007-9513-z. Epub 2008 Jan 15.

PMID:
18196205
5.

Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.

Feng SS, Mei L, Anitha P, Gan CW, Zhou W.

Biomaterials. 2009 Jul;30(19):3297-306. doi: 10.1016/j.biomaterials.2009.02.045. Epub 2009 Mar 19.

PMID:
19299012
7.

Docetaxel Loaded PEG-PLGA Nanoparticles: Optimized Drug Loading, In-vitro Cytotoxicity and In-vivo Antitumor Effect.

Noori Koopaei M, Khoshayand MR, Mostafavi SH, Amini M, Khorramizadeh MR, Jeddi Tehrani M, Atyabi F, Dinarvand R.

Iran J Pharm Res. 2014 Summer;13(3):819-33.

8.

Antitumor activity of docetaxel-loaded polymeric nanoparticles fabricated by Shirasu porous glass membrane-emulsification technique.

Yu Y, Tan S, Zhao S, Zhuang X, Song Q, Wang Y, Zhou Q, Zhang Z.

Int J Nanomedicine. 2013;8:2641-52. doi: 10.2147/IJN.S48214. Epub 2013 Jul 29.

9.

Paclitaxel-loaded polyester nanoparticles prepared by spray-drying technology: in vitro bioactivity evaluation.

López-Gasco P, Iglesias I, Benedí J, Lozano R, Teijón JM, Blanco MD.

J Microencapsul. 2011;28(5):417-29. doi: 10.3109/02652048.2011.576785.

PMID:
21736526
10.

In-vitro evaluation of paclitaxel-loaded MPEG-PLGA nanoparticles on laryngeal cancer cells.

Gao C, Pan J, Lu W, Zhang M, Zhou L, Tian J.

Anticancer Drugs. 2009 Oct;20(9):807-14. doi: 10.1097/CAD.0b013e328330c811.

PMID:
19696655
11.

Development of novel cationic chitosan-and anionic alginate-coated poly(D,L-lactide-co-glycolide) nanoparticles for controlled release and light protection of resveratrol.

Sanna V, Roggio AM, Siliani S, Piccinini M, Marceddu S, Mariani A, Sechi M.

Int J Nanomedicine. 2012;7:5501-16. doi: 10.2147/IJN.S36684. Epub 2012 Oct 17.

12.

Antitumor efficiency of D-alpha-tocopheryl polyethylene glycol 1000 succinate-b-poly(epsilon-caprolactone-ran-lactide) nanoparticle-based delivery of docetaxel in mice bearing cervical cancer.

Wang Z, Zeng X, Ma Y, Liu J, Tang X, Gao Y, Liu K, Zhang J, Ming P, Huang L, Mei L.

J Biomed Nanotechnol. 2014 Aug;10(8):1509-19.

PMID:
25016651
13.

Biodegradable core-shell nanoassemblies for the delivery of docetaxel and Zn(II)-phthalocyanine inspired by combination therapy for cancer.

Conte C, Ungaro F, Maglio G, Tirino P, Siracusano G, Sciortino MT, Leone N, Palma G, Barbieri A, Arra C, Mazzaglia A, Quaglia F.

J Control Release. 2013 Apr 10;167(1):40-52. doi: 10.1016/j.jconrel.2012.12.026. Epub 2013 Jan 5.

PMID:
23298613
15.

Nanoparticle-based topical ophthalmic formulations for sustained celecoxib release.

Ibrahim MM, Abd-Elgawad AE, Soliman OA, Jablonski MM.

J Pharm Sci. 2013 Mar;102(3):1036-53. doi: 10.1002/jps.23417. Epub 2013 Jan 3.

PMID:
23293035
16.

Comparative evaluation of in vitro parameters of tamoxifen citrate loaded poly(lactide-co-glycolide), poly(epsilon-caprolactone) and chitosan nanoparticles.

Cirpanli Y, Yerlikaya F, Ozturk K, Erdogar N, Launay M, Gegu C, Leturgez T, Bilensoy E, Calis S, Capan Y.

Pharmazie. 2010 Dec;65(12):867-70.

PMID:
21284254
17.

Docetaxel-loaded nanoparticles based on star-shaped mannitol-core PLGA-TPGS diblock copolymer for breast cancer therapy.

Tao W, Zeng X, Liu T, Wang Z, Xiong Q, Ouyang C, Huang L, Mei L.

Acta Biomater. 2013 Nov;9(11):8910-20. doi: 10.1016/j.actbio.2013.06.034. Epub 2013 Jun 28.

PMID:
23816645
18.

Docetaxel-loaded polylactic acid-co-glycolic acid nanoparticles: formulation, physicochemical characterization and cytotoxicity studies.

Pradhan R, Poudel BK, Ramasamy T, Choi HG, Yong CS, Kim JO.

J Nanosci Nanotechnol. 2013 Aug;13(8):5948-56.

PMID:
23882865
19.

Paclitaxel-loaded poly(glycolide-co-ε-caprolactone)-b-D-α-tocopheryl polyethylene glycol 2000 succinate nanoparticles for lung cancer therapy.

Zhao T, Chen H, Dong Y, Zhang J, Huang H, Zhu J, Zhang W.

Int J Nanomedicine. 2013;8:1947-57. doi: 10.2147/IJN.S44220. Epub 2013 May 16.

20.

Resveratrol-loaded nanoparticles based on poly(epsilon-caprolactone) and poly(D,L-lactic-co-glycolic acid)-poly(ethylene glycol) blend for prostate cancer treatment.

Sanna V, Siddiqui IA, Sechi M, Mukhtar H.

Mol Pharm. 2013 Oct 7;10(10):3871-81. doi: 10.1021/mp400342f. Epub 2013 Sep 4.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk